HIV Env reduction postreceptor binding: a new target for AIDS treatment?
Open Access
- 1 July 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (1) , 296
- https://doi.org/10.1182/blood-2004-03-1176
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entryBlood, 2004
- HIV envelope becomes unhinged by PDI for entryBlood, 2004
- Protein-disulfide Isomerase-mediated Reduction of Two Disulfide Bonds of HIV Envelope Glycoprotein 120 Occurs Post-CXCR4 Binding and Is Required for FusionJournal of Biological Chemistry, 2003
- Inhibitors of Protein-Disulfide Isomerase Prevent Cleavage of Disulfide Bonds in Receptor-bound Glycoprotein 120 and Prevent HIV-1 EntryJournal of Biological Chemistry, 2002
- Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1Nature Immunology, 2002
- The Catalytic Activity of Protein Disulfide Isomerase Is Involved in Human Immunodeficiency Virus Envelope–Mediated Membrane Fusion after CD4 Cell BindingThe Journal of Infectious Diseases, 2001
- A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984)Biochimica et Biophysica Acta (BBA) - Biomembranes, 1997
- Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction.Proceedings of the National Academy of Sciences, 1994